Hyperprolactinemia is usually a aspect result of dopamine antagonists as blockade of D2 receptors inside the tuberoinfundibular pathway results in increased plasma amounts of prolactin as a consequence of amplified secretion by lactotrophs from the anterior pituitary. Making use of this medicatio